Anticipatory anxiety and participation in cancer screening. A systematic review.

anxiety cancer delivery of healthcare early detection of cancer oncology patient acceptance of health care prevention and control screening

Journal

Psycho-oncology
ISSN: 1099-1611
Titre abrégé: Psychooncology
Pays: England
ID NLM: 9214524

Informations de publication

Date de publication:
Dec 2023
Historique:
revised: 20 10 2023
received: 01 08 2023
accepted: 21 10 2023
pubmed: 6 11 2023
medline: 6 11 2023
entrez: 6 11 2023
Statut: ppublish

Résumé

To synthesize current evidence on the association between anticipatory anxiety, defined as apprehension-specific negative affect that may be experienced when exposed to potential threat or uncertainty, and cancer screening to better inform strategies to maximize participation rates. Searches related to cancer screening and anxiety were conducted in seven electronic databases (APA PsycINFO, Scopus, Web of Science, Embase, Cochrane Library, PubMed, CINAHL), with potentially eligible papers screened in Covidence. Data extraction was conducted independently by multiple authors. Barriers to cancer screening for any type of cancer and relationships tested between anticipatory anxiety and cancer screening and intention were categorized and compared according to the form and target of anxiety and cancer types. A total of 74 articles (n Anticipatory anxiety about a cancer diagnosis may promote screening participation, whereas a fear of the screening procedure could be a barrier. Public health messaging and primary prevention practitioners should acknowledge the appropriate risk of cancer, while engendering screening confidence and highlighting the safety and comfort of screening tests.

Identifiants

pubmed: 37929985
doi: 10.1002/pon.6238
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1773-1786

Subventions

Organisme : Cancer Institute of New South Wales
ID : 2020/ECF1163
Organisme : Cancer Australia

Informations de copyright

© 2023 John Wiley & Sons Ltd.

Références

Etzioni R, Urban N, Ramsey S, et al. The case for early detection. Nat Rev Cancer. 2003;3(4):243-252. https://doi.org/10.1038/nrc1041
Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer. 2004;101(S5):1201-1213. https://doi.org/10.1002/cncr.20505
Navarro M, Nicolas A, Ferrandez A, Lanas A. Colorectal cancer population screening programs worldwide in 2016: an update. World J Gastroenterol. 2017;23(20):3632. https://doi.org/10.3748/wjg.v23.i20.3632
Luo C, Wang L, Zhang Y, et al. Advances in breast cancer screening modalities and status of global screening programs. Chronic Dis Transl Med. 2022;8(2):112-123. https://doi.org/10.1002/cdt3.21
Bruni L, Serrano B, Roura E, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Glob Health. 2022;10(8):e1115-e1127. https://doi.org/10.1016/S2214-109X(22)00241-8
Goodwin BC, Myers L, Ireland MJ, et al. Barriers to home bowel cancer screening. Psycho Oncol. 2021;30(10):1756-1764. https://doi.org/10.1002/pon.5741
Bukowska-Durawa A, Luszczynska A. Cervical cancer screening and psychosocial barriers perceived by patients. A systematic review. Contemp Oncol Onkol. 2014;18(3):153-159. https://doi.org/10.5114/wo.2014.43158
Goodwin BC, March S, Crawford-Williams F, Chambers SK, Dunn J. “I’m not doing that.” an in-depth examination of nonparticipation in mail-out bowel cancer screening programs. Transl Behav Med. 2020;10(6):1515-1524.
Hall NJ, Rubin GP, Dobson C, et al. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer. Health Expect. 2015;18(5):1645-1657. https://doi.org/10.1111/hex.12157
Lim JNW, Ojo AA. Barriers to utilisation of cervical cancer screening in Sub Sahara Africa: a systematic review. Eur J Cancer Care. 2017;26(1):e12444. https://doi.org/10.1111/ecc.12444
Clark LA, Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol. 1991;100(3):316-336. https://doi.org/10.1037/0021-843x.100.3.316
Behar E, Alcaine O, Zuellig AR, Borkovec TD. Screening for generalized anxiety disorder using the Penn State Worry Questionnaire: a receiver operating characteristic analysis. J Behav Ther Exp Psychiatry. 2003;34(1):25-43. https://doi.org/10.1016/s0005-7916(03)00004-1
Brosschot JF, Gerin W, Thayer JF. The perseverative cognition hypothesis: a review of worry, prolonged stress-related physiological activation, and health. J Psychosom Res. 2006;60(2):113-124. https://doi.org/10.1016/j.jpsychores.2005.06.074
Jørgensen MD, Mikkelsen EM, Erichsen R, Thomsen MK. Mental illness and participation in colorectal cancer screening: a scoping review. Scand J Gastroenterol. 2022;31:1-11. https://doi.org/10.1080/00365521.2022.2073185
Kisely S, Crowe E, Lawrence D. Cancer-related mortality in people with mental illness. JAMA Psychiatr. 2013;70(2):209-217. https://doi.org/10.1001/jamapsychiatry.2013.278
Moodi M, Rezaeian M, Mostafavi F, Sharifirad GR. Determinants of mammography screening behavior in Iranian women: a population-based study. J Res Med Sci Off J Isfahan Univ Med Sci. 2012;17(8):750-759.
Anderson LE, Ireland MJ, Myers L, Avenell C, Connaughton T, Goodwin BC. Psychological distress and bowel cancer screening participation. Psycho Oncol. 2022;32(2):229-236. Published online. https://doi.org/10.1002/pon.6072
Austin LT, Ahmad F, McNally MJ, Stewart DE. Breast and cervical cancer screening in Hispanic women: a literature review using the health belief model. Womens Health Issues. 2002;12(3):122-128. https://doi.org/10.1016/S1049-3867(02)00132-9
Consedine NS, Magai C, Krivoshekova YS, Ryzewicz L, Neugut AI. Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Prev Biomark. 2004;13(4):501-510. https://doi.org/10.1158/1055-9965.501.13.4
Hay JL, McCaul KD, Magnan RE. Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med. 2006;42(6):401-408. https://doi.org/10.1016/j.ypmed.2006.03.002
Chad-Friedman E, Coleman S, Traeger LN, et al. Psychological distress associated with cancer screening: a systematic review. Cancer. 2017;123(20):3882-3894. https://doi.org/10.1002/cncr.30904
Clarivate. EndNote | the Best Reference Management Tool. EndNote; 2023. Published. Accessed 15 June 2023. https://endnote.com/
Veritas Health Innovation. Covidence Systematic Review Software. 2022. www.covidence.org
Joanna Briggs Institute. © Joanna Briggs Institute 2017 Critical Appraisal Checklist for Analytical Cross Sectional Studies; 2020. Published online.
Jibara G, Jandorf L, Fodera MB, DuHamel KN. Adherence to physician recommendation to colorectal cancer screening colonoscopy among Hispanics. J Gen Intern Med. 2011;26(10):1124-1130. https://doi.org/10.1007/s11606-011-1727-4
Castaldi M, Smiley A, Kechejian K, Butler J, Latifi R. Disparate access to breast cancer screening and treatment. BMC Wom Health. 2022;22(1):249. https://doi.org/10.1186/s12905-022-01793-z
Prathibha S, Westanmo AD, Hui JYC, et al. Breast cancer and women veterans: what is the impact of mental health on screening rates? Med Basel Switz. 2022;10(1):1. https://doi.org/10.3390/medicines10010001
Davis SN, Christy SM, Chavarria EA, et al. A randomized controlled trial of a multicomponent, targeted, low-literacy educational intervention compared with a nontargeted intervention to boost colorectal cancer screening with fecal immunochemical testing in community clinics. Cancer. 2017;123(8):1390-1400. https://doi.org/10.1002/cncr.30481
Ojinnaka C, Vuong A, Helduser J, et al. Determinants of variations in self-reported barriers to colonoscopy among uninsured patients in a primary care setting. J Community Health. 2015;40(2):260-270. https://doi.org/10.1007/s10900-014-9925-8
Robinson CM, Cassells AN, Greene MA, Beach ML, Tobin JN, Dietrich AJ. Barriers to colorectal cancer screening among publicly insured urban women: no knowledge of tests and no clinician recommendation. J Natl Med Assoc. 2011;103(8):746-753. https://doi.org/10.1016/s0027-9684(15)30414-4
van Dam L, Korfage IJ, Kuipers EJ, et al. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy? Eur J Cancer Oxf Engl 1990. 2013;49(10):2321-2330. https://doi.org/10.1016/j.ejca.2013.03.007
Gordon DR, Venturini A, Rosselli Del Turco M, Palli D, Paci E. What healthy women think, feel and do about cancer, prevention and breast cancer screening in Italy. Eur J Cancer Clin Oncol. 1991;27(7):913-917. https://doi.org/10.1016/0277-5379(91)90146-5
Salem MR, Amin TT, Alhulaybi AA, Althafar AS, Abdelhai RA. Perceived risk of cervical cancer and barriers to screening among secondary school female teachers in Al Hassa, Saudi Arabia. Asian Pac J Cancer Prev APJCP. 2017;18(4):969-979. https://doi.org/10.22034/APJCP.2017.18.4.969
Wanyenze RK, Bwanika JB, Beyeza-Kashesya J, et al. Uptake and correlates of cervical cancer screening among HIV-infected women attending HIV care in Uganda. Glob Health Action. 2017;10(1):1380361. https://doi.org/10.1080/16549716.2017.1380361
Percac-Lima S, Ashburner JM, Atlas SJ, et al. Barriers to and interest in lung cancer screening among Latino and non-Latino current and former smokers. J Immigr Minor Health. 2019;21(6):1313-1324. https://doi.org/10.1007/s10903-019-00860-2
Quaife SL, Marlow LAV, McEwen A, Janes SM, Wardle J. Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication. Health Expect. 2017;20(4):563-573. https://doi.org/10.1111/hex.12481
Raju S, Khawaja A, Han X, Wang X, Mazzone PJ. Lung cancer screening: characteristics of nonparticipants and potential screening barriers. Clin Lung Cancer. 2020;21(5):e329-e336. https://doi.org/10.1016/j.cllc.2019.11.016
Prisha P, Tan KS, Lee CP. Malaysian women’s viewpoint on HPV screening and vaccination: a study on barriers. Vaccines. 2023;11(1):139. https://doi.org/10.3390/vaccines11010139
Huang Z, Liu W, Marzo RR, Hu Z, Wong LP, Lin Y. High-risk population’s knowledge of risk factors and warning symptoms and their intention toward gastric cancer screening in Southeastern China. Front Public Health. 2022;10:974923. https://doi.org/10.3389/fpubh.2022.974923
Gordon NP, Green BB. Factors associated with use and non-use of the Fecal Immunochemical Test (FIT) kit for colorectal cancer screening in response to a 2012 outreach screening program: a survey study. BMC Publ Health. 2015;15(1):546. https://doi.org/10.1186/s12889-015-1908-x
Moser RP, Mccaul K, Peters E, Nelson W, Marcus SE. Associations of perceived risk and worry with cancer health-protective actions: data from the health information national trends survey (HINTS). J Health Psychol. 2007;12(1):53-65. https://doi.org/10.1177/1359105307071735
Vrinten C, Stoffel S, Dodd RH, Waller J, Lyratzopoulos Y, von Wagner C. Cancer worry frequency vs. intensity and self-reported colorectal cancer screening uptake: a population-based study. J Med Screen. 2019;26(4):169-178. https://doi.org/10.1177/0969141319842331
Wardle J, McCaffery K, Nadel M, Atkin W. Socioeconomic differences in cancer screening participation: comparing cognitive and psychosocial explanations. Soc Sci Med. 2004;59(2):249-261. https://doi.org/10.1016/j.socscimed.2003.10.030
Sach TH, Whynes DK. Men and women: beliefs about cancer and about screening. BMC Publ Health. 2009;9(1):431. https://doi.org/10.1186/1471-2458-9-431
Ferrer RA, Hall KL, Portnoy DB, Ling BS, Han PKJ, Klein WMP. Relationships among health perceptions vary depending on stage of readiness for colorectal cancer screening. Health Psychol. 2011;30(5):525-535. https://doi.org/10.1037/a0023583
Choi E, Lee YY, Yoon HJ, et al. Relationship between cancer worry and stages of adoption for breast cancer screening among Korean women. PLOS ONE. 2015;10(7):e0132351. https://doi.org/10.1371/journal.pone.0132351
Honda K, Goodwin RD, Neugut AI. The associations between psychological distress and cancer prevention practices. Cancer Detect Prev. 2005;29(1):25-36. https://doi.org/10.1016/j.cdp.2004.08.004
Klasko-Foster LB, Jandorf LM, Erwin DO, Kiviniemi MT. Predicting colonoscopy screening behavior and future screening intentions for African Americans older than 50 years. Behav Med. 2019;45(3):221-230. https://doi.org/10.1080/08964289.2018.1510365
Choi E, Lee YY, Suh M, et al. Associations of perceived risk and cancer worry for colorectal cancer with screening behaviour. J Health Psychol. 2018;23(6):840-852. https://doi.org/10.1177/1359105316679721
Jimbo M, Sen A, Plegue MA, et al. Correlates of patient intent and preference on colorectal cancer screening. Am J Prev Med. 2017;52(4):443-450. https://doi.org/10.1016/j.amepre.2016.11.026
Sun WY, Basch CE, Wolf RL, Li XJ. Factors associated with colorectal cancer screening among Chinese-Americans. Prev Med. 2004;39(2):323-329. https://doi.org/10.1016/j.ypmed.2004.04.029
Bynum SA, Davis JL, Green BL, Katz RV. Unwillingness to participate in colorectal cancer screening: examining fears, attitudes, and medical mistrust in an ethnically diverse sample of adults 50 years and older. https://doi.org/10.4278/ajhp.110113-QUAN-20
Wei W, Zhang M, Zuo D, et al. Screening intention prediction of colorectal cancer among urban Chinese based on the protection motivation theory. Int J Environ Res Public Health. 2022;19(7):4203. https://doi.org/10.3390/ijerph19074203
Watts BG, Vernon SW, Myers RE, Tilley BC. Intention to Be Screened over Time for Colorectal Cancer in Male Automotive Workers; 2003. Published online.
Llanos AA, Pennell ML, Young GS, Tatum CM, Katz ML, Paskett ED. No association between colorectal cancer worry and screening uptake in Appalachian Ohio. J Public Health. 2015;37(2):322-327. https://doi.org/10.1093/pubmed/fdu031
Rogers CR, Robinson CD, Arroyo C, Obidike OJ, Sewali B, Okuyemi KS. Colorectal Cancer Screening Uptake’s Association with Psychosocial and Sociodemographic Factors Among Homeless Blacks and Whites. Published 2017. Accessed February 21, 2023. https://journals-sagepub-com.ezproxy.library.uq.edu.au/doi/full/10.1177/1090198117734284
Antill YC, Reynolds J, Young MA, et al. Screening behavior in women at increased familial risk for breast cancer. Fam Cancer. 2006;5(4):359-368. https://doi.org/10.1007/s10689-006-0006-8
Price MA, Butow PN, Charles M, et al. Predictors of breast cancer screening behavior in women with a strong family history of the disease. Breast Cancer Res Treat. 2010;124(2):509-519. https://doi.org/10.1007/s10549-010-0868-1
Epstein SA, Hsiang Lin T, Audrain J, Stefanek M, Rimer B, Lerman C. Excessive breast self-examination among first-degree relatives of newly diagnosed breast cancer patients. Psychosomatics. 1997;38(3):253-261. https://doi.org/10.1016/S0033-3182(97)71462-2
Aro AR, de Koning HJ, Absetz P, Schreck M. Psychosocial predictors of first attendance for organised mammography screening. J Med Screen. 1999;6(2):82-88. https://doi.org/10.1136/jms.6.2.82
Hersch J, McGeechan K, Barratt A, et al. How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial. BMJ Open. 2017;7(10):e016246. https://doi.org/10.1136/bmjopen-2017-016246
Tran ATN, Hwang JH, Choi E, et al. Impact of awareness of breast density on perceived risk, worry, and intentions for future breast cancer screening among Korean women. Cancer Res Treat. 2021;53(1):55-64. https://doi.org/10.4143/crt.2020.495
Bowen DJ, Helmes A, Powers D, et al. Predicting breast cancer screening intentions and behavior with emotion and cognition. J Soc Clin Psychol. 2003;22(2):213-232. https://doi.org/10.1521/jscp.22.2.213.22875
Diefenbach MA, Miller SM, Daly MB. Specific worry about breast cancer predicts mammography use in women at risk for breast and ovarian cancer. Health Psychol. 1999;18(5):532-536. https://doi.org/10.1037/0278-6133.18.5.532
Kudadjie-Gyamfi E, Consedine N, Magai C, Gillespie M, Pierre-Louis J. Breast self-examination practices among women from six ethnic groups and the influence of cancer worry. Breast Cancer Res Treat. 2005;92(1):35-45. https://doi.org/10.1007/s10549-005-0154-9
Williams-Piehota P, Schneider TR, Pizarro J, Mowad L, Salovey P. Matching health messages to information-processing styles: need for cognition and mammography utilization. Health Commun. 2003;15(4):375-392. https://doi.org/10.1207/S15327027HC1504_01
Foxall MJ, Barron CR, Houfek JF. Ethnic Influences on Body Awareness, Trait Anxiety, Perceived Risk, and Breast and Gynecologic Cancer Screening Practices; 2001. Published. Accessed 15 June 2023. https://web.p.ebscohost.com/abstract?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=0190535X&AN=9521935&h=pc3Xh3DS1oS0O1%2f%2bvGNzhMuJTvstrg01iDDCwSvhamPjCbTFucISGPf2rolnUqZxe7GEh5SrxB50Aou9985ohQ%3d%3d&crl=c&resultNs=AdminWebAuth&resultLocal=ErrCrlNotAuth&crlhashurl=login.aspx%3fdirect%3dtrue%26profile%3dehost%26scope%3dsite%26authtype%3dcrawler%26jrnl%3d0190535X%26AN%3d9521935
Jensen LF, Pedersen AF, Andersen B, Vestergaard M, Vedsted P. Non-participation in breast cancer screening for women with chronic diseases and multimorbidity: a population-based cohort study. BMC Cancer. 2015;15(1):1-10. https://doi.org/10.1186/s12885-015-1829-1
Kash KM, Holland JC, Halper MS, Miller DG. Psychological distress and surveillance behaviors of women with a family history of breast cancer. JNCI J Natl Cancer Inst. 1992;84(1):24-30. https://doi.org/10.1093/jnci/84.1.24
Lerman C, Rimer B, Trock B, Balshem A, Engstrom PF. Factors associated with repeat adherence to breast cancer screening. Prev Med. 1990;19(3):279-290. https://doi.org/10.1016/0091-7435(90)90028-I
Seitz HH, Schapira MM, Gibson LA, et al. Explaining the effects of a decision intervention on mammography intentions: the roles of worry, fear and perceived susceptibility to breast cancer. Psychol Health. 2018;33(5):682-700. https://doi.org/10.1080/08870446.2017.1387261
Young RF, Waller JB, Smitherman H. A breast cancer education and on-site screening intervention for unscreened African American women. J Cancer Educ. 2002;17(4):231-236.
Zhuang J, Guan M. Modeling the mediating and moderating roles of risk perceptions, efficacy, desired uncertainty, and worry in information seeking-cancer screening relationship using HINTS 2017 data. Health Commun. 2022;37(7):897-908. https://doi.org/10.1080/10410236.2021.1876324
Ahmed N, Fort J, Malin A, Hargreaves M. Barriers to mammography screening in a managed care population. Public Adm Manag. 2009;14.
López-Panisello MB, Pérez-Lacasta MJ, Rué M, Carles-Lavila M. Factors influencing intention to participate in breast cancer screening. An exploratory structural model. PloS One. 2023;18(2):e0281454. https://doi.org/10.1371/journal.pone.0281454
Flores-Luevano S, Shokar NK, Dwiveldi AK, Shokar GS, Defeu SN. Breast Cancer Fear Among Mexican American Women in the United States; 2020. Published. Accessed 15 June 2023. https://journals.sagepub.com/doi/full/10.1177/1178223420952745
Graves KD, Huerta E, Cullen J, et al. Perceived risk of breast cancer among Latinas attending community clinics: risk comprehension and relationship with mammography adherence. Cancer Causes Control. 2008;19(10):1373-1382. https://doi.org/10.1007/s10552-008-9209-7
Isaacs C, Peshkin BN, Schwartz M, DeMarco TA, Main D, Lerman C. Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat. 2002;71(2):103-112. https://doi.org/10.1023/a:1013800409238
Jo Hailey CLC Darla B, Burnett Breast Cancer Attitudes R. Knowledge, and screening behavior in women with and without a family history of breast cancer. Health Care Women Int. 2000;21(8):701-715. https://doi.org/10.1080/073993300300340529
Miller SJ, O’Hea EL, Lerner JB, Moon S, Foran-Tuller KA. The relationship between breast cancer anxiety and mammography: experiential avoidance as a moderator. Behav Med. 2011;37(4):113-118. https://doi.org/10.1080/08964289.2011.614291
Sutton S, Bickler G, Sancho-Aldridge J, Saidi G. Prospective study of predictors of attendance for breast screening in inner London. J Epidemiol Community Health. 1994;48(1):65-73. https://doi.org/10.1136/jech.48.1.65
Sutton S, Saidi G, Bickler G, Hunter J. Does routine screening for breast cancer raise anxiety? Results from a three wave prospective study in England. J Epidemiol Community Health 1979-. 1995;49(4):413-418. https://doi.org/10.1136/jech.49.4.413
Walker LG, Cordiner CM, Gilbert FJ, et al. How Distressing Is Attendance for Routine Breast Screening? 1994. Published. Accessed 15 June 2023. https://onlinelibrary-wiley-com.ezproxy.library.uq.edu.au/doi/abs/10.1002/pon.2960030406
Perez LG, Elder JP, Haughton J, Martinez ME, Arredondo EM. Socio-demographic moderators of associations between psychological factors and Latinas’ breast cancer screening behaviors. J Immigr Minor Health. 2018;20(4):823-830. https://doi.org/10.1007/s10903-017-0633-1
Krok-Schoen JL, Oliveri JM, Young GS, Katz ML, Tatum CM, Paskett ED. Evaluating the stage of change model to a cervical cancer screening intervention among Ohio Appalachian women. Women Health. 2016;56(4):468-486. https://doi.org/10.1080/03630242.2015.1101736
Harder E, Thomsen LT, Hertzum-Larsen R, et al. Determinants for participation in human papillomavirus self-sampling among nonattenders to cervical cancer screening in Denmark. Cancer Epidemiol Biomarkers Prev. 2018;27(11):1342-1351. https://doi.org/10.1158/1055-9965.EPI-18-0480
Brown RF, Muller TR, Olsen A. Australian women’s cervical cancer screening attendance as a function of screening barriers and facilitators. Soc Sci Med. 2019;220:396-402. https://doi.org/10.1016/j.socscimed.2018.11.038
Zhao X, Nan X. The influence of absolute and comparative risk perceptions on cervical cancer screening and the mediating role of cancer worry. J Health Commun. 2016;21(1):100-108. https://doi.org/10.1080/10810730.2015.1033114
Wong AOY, Ho KS, Chan WM. Factors affecting participation in cervical cancer screening among elderly Chinese women. Hong Kong Pract. 2005;27(6):223-229.
See K, Manser R, Park ER, et al. The impact of perceived risk, screening eligibility and worry on preference for lung cancer screening: a cross-sectional survey. ERJ Open Res. 2020;6(1):00158-02019. https://doi.org/10.1183/23120541.00158-2019
Andersen MR, Peacock S, Nelson J, et al. Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. Gynecol Oncol. 2002;85(1):3-8. https://doi.org/10.1006/gyno.2001.6556
Bloom JR, Stewart SL, Oakley-Girvans I, Banks PJ, Chang S. Family history, perceived risk, and prostate cancer screening among African American men. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2167-2173. https://doi.org/10.1158/1055-9965.EPI-05-0738
Kotwal AA, Schumm P, Mohile SG, Dale W. The Influence of Stress, Depression, and Anxiety on PSA Screening Rates in a Nationally Representative Sample on JSTOR; 2012. Published. Accessed 15 June 2023. https://www-jstor-org.ezproxy.library.uq.edu.au/stable/41714630?sid=primo
Benedict MOA, Steinberg WJ, Claassen FM, Mofolo N, van Rooyen C. Knowledge, beliefs and intentions of African men in the Free State about prostate cancer screening. Health SA SA Gesondheid. 2022;27:2081. https://doi.org/10.4102/hsag.v27i0.2081
Sweetman J, Watson M, Norman A, et al. Feasibility of Familial PSA Screening: Psychosocial Issues and Screening Adherence; 2006. Published. Accessed 15 June 2023. https://www-nature-com.ezproxy.library.uq.edu.au/articles/6602959
Franke FS, Matthäi E, Slater EP, Schicker C, Kruse J, Bartsch DK. German National Case Collection for familial pancreatic Cancer (FaPaCa) - acceptance and psychological aspects of a pancreatic cancer screening program. Hered Cancer Clin Pract. 2018;16(1):17. https://doi.org/10.1186/s13053-018-0100-6
Breitkopf CR, Sinicrope PS, Rabe KG, et al. Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history. Hered Cancer Clin Pract. 2012;10(1):8. https://doi.org/10.1186/1897-4287-10-8
Peters Y, van Grinsven E, van de Haterd M, van Lankveld D, Verbakel J, Siersema PD. Individuals’ preferences for esophageal cancer screening: a discrete choice experiment. Value Health. 2020;23(8):1087-1095. https://doi.org/10.1016/j.jval.2020.03.013
Humphris GM, Ireland RS, Field EA. Randomised trial of the psychological effect of information about oral cancer in primary care settings. Oral Oncol. 2001;37(7):548-552. https://doi.org/10.1016/S1368-8375(01)00017-3
Maner JK, Schmidt NB. The role of risk avoidance in anxiety. Behav Ther. 2006;37(2):181-189. https://doi.org/10.1016/j.beth.2005.11.003
Schwarzer R, Luszczynska A. How to Overcome Health-Compromising Behaviors: The Health Action Process Approach; 2008. Published. Accessed 11 January 2023. https://psycnet-apa-org.ezproxy.library.uq.edu.au/fulltext/2008-06444-006.html
Rosenstock IM. The health belief model: explaining health behavior through expectancies. In: Health Behavior and Health Education: Theory, Research, and Practice. The Jossey-Bass health series. Jossey-Bass/Wiley; 1990:39-62.
Hay JL, Buckley TR, Ostroff JS. The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psycho Oncol. 2005;14(7):517-534. https://doi.org/10.1002/pon.864
Flynn PM, Betancourt H, Ormseth SR. Culture, emotion, and cancer screening: an integrative framework for investigating health behavior. Ann Behav Med. 2011;42(1):79-90. https://doi.org/10.1007/s12160-011-9267-z
Facione NC, Katapodi M. Culture as an influence on breast cancer screening and early detection. Semin Oncol Nurs. 2000;16(3):238-247. https://doi.org/10.1053/sonc.2000.8118
Smith LH. Selection mechanisms and their consequences: understanding and addressing selection bias. Curr Epidemiol Rep. 2020;7(4):179-189. https://doi.org/10.1007/s40471-020-00241-6
Hailey BJ. Family history of breast cancer and screening behavior: an inverted U-shaped curve? Med Hypotheses. 1991;36(4):397-403. https://doi.org/10.1016/0306-9877(91)90019-U
Kirkøen B, Berstad P, Hoff G, et al. Type and severity of mental illness and participation in colorectal cancer screening. Am J Prev Med. 2023;64(1):76-85. https://doi.org/10.1016/j.amepre.2022.08.011
US Preventative Services Taskforce. Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement | Cancer Screening, Prevention, Control. JAMA | JAMA Network; 2018. Published. Accessed 16 June 2023. https://jamanetwork.com/journals/jama/article-abstract/2672638
Duffy MJ. Chapter one-PSA in screening for prostate cancer: more good than harm or more harm than good? In: Makowski GS, ed. Advances in Clinical Chemistry. Vol 66. Elsevier; 2014:1-23. https://doi.org/10.1016/B978-0-12-801401-1.00001-3
Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the US preventive services task force. Ann Intern Med. 2011;155(11):762-771. https://doi.org/10.7326/0003-4819-155-11-201112060-00375
Dean M, Davidson LG. Previvors’ uncertainty management strategies for hereditary breast and ovarian cancer. Health Commun. 2018;33(2):122-130. https://doi.org/10.1080/10410236.2016.1250187

Auteurs

Belinda Goodwin (B)

Viertel Cancer Research Centre, Cancer Council Queensland, Fortitude Valley, Queensland, Australia.
Centre for Health Research, University of Southern Queensland, Springfield, Queensland, Australia.
Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.

Laura Anderson (L)

Viertel Cancer Research Centre, Cancer Council Queensland, Fortitude Valley, Queensland, Australia.
National Centre for Youth Substance Use Research, The University of Queensland, Saint Lucia, Queensland, Australia.

Katelyn Collins (K)

Viertel Cancer Research Centre, Cancer Council Queensland, Fortitude Valley, Queensland, Australia.
School of Psychology and Wellbeing, University of Southern Queensland, Springfield, Queensland, Australia.

Saira Sanjida (S)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.
Poche Centre for Indigenous Health, The University of Queensland, Brisbane, Queensland, Australia.

Marcos Riba (M)

The University of Queensland, Saint Lucia, Queensland, Australia.

Gursharan K Singh (GK)

Centre for Healthcare Transformation, Faculty of Health, Queensland University of Technology (QUT), Brisbane, Queensland, Australia.
Cancer and Palliative Outcomes Centre, School of Nursing, Queensland University of Technology (QUT), Brisbane, Queensland, Australia.

Kimberley M Campbell (KM)

IMPACCT, Faculty of Health, University of Technology Sydney, Ultimo, New South Wales, Australia.

Heather Green (H)

School of Applied Psychology and Menzies Health Institute Queensland, Griffith University, Gold Coast, Queensland, Australia.

Sana Ishaque (S)

College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.

Alastair Kwok (A)

Department of Medicine, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.
Department of Oncology, Monash Health, Clayton, Victoria, Australia.

Melissa J Opozda (MJ)

Freemasons Centre for Male Health and Wellbeing, South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, South Australia, Australia.
College of Medicine and Public Health, Flinders University, Darwin, Northern Territory, Australia.

Amy Pearn (A)

The Gene Council, North Perth, Washington, Australia.

Joanne Shaw (J)

Psycho-oncology Co-operative Research Group, School of Psychology, Faculty of Science, The University of Sydney, Camperdown, New South Wales, Australia.

Ursula M Sansom-Daly (UM)

Psycho-oncology Co-operative Research Group, School of Psychology, Faculty of Science, The University of Sydney, Camperdown, New South Wales, Australia.
School of Clinical Medicine, UNSW Medicine & Health, Randwick Clinical Campus, Discipline of Paediatrics, UNSW Sydney, Kensington, New South Wales, Australia.
Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.

Joanna M Tsirgiotis (JM)

Sydney Youth Cancer Centre, Nelune Comprehensive Cancer Centre, Prince of Wales Hospital, Randwick, New South Wales, Australia.

Monika Janda (M)

Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia.

Lisa Grech (L)

Department of Medicine, School of Clinical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia.

Classifications MeSH